Randomized trial in NEJM of >900 CLL patient (without tp53 mutation) randomized to Ven-Obi, Ven-Obi-Ibr, chemo (with BR or FCR) or Ven-rituximab showed improved PFS at 3 years for the Obi containing arms vs chemo but not the Ven-Rituximab arm. There was no difference seen in OS. Patients with mutated IGVH did well in all groups without significant difference in outcomes.
Mentee Robotics has pulled back the curtain on MenteeBot, a personalized humanoid robot that fully integrates AI across all operational aspects.
How neurorehabilitation at Cleveland Clinic London Hospital enabled a 34-year-old to fully recover from traumatic brain injury following devastating ski accident
A local health care company is studying whether administering cannabidiol, a non-intoxicating component of cannabis, can reduce the need for opioids after surgery.
Pastor Chris Oyakhilome is targeting the new malaria vaccines as African countries start their rollout.
Background Iron deficiency is highly prevalent worldwide and is an issue of health inequity. Despite its high prevalence, uncertainty on the clinical applicability and evidence-base…
WASHINGTON — Genetic testing can provide answers about children who may have primary immunodeficiencies when antibody and cell testing meet their limits, according to a…
An abstract is unavailable.
Chronic wasting disease (CWD) is a prion disease that affects North American cervids (hoofed ruminant mammals, with males characteristically having antlers).
Rep. Michael Burgess (R-TX) told HHS Secretary Xavier Becerra that implementing uniform payments for health care services across all settings, whether in a physician’s office…
Listen to this episode from My Safe Word Is More on Spotify. In this week’s episode of we have a special guest and more importantly,…
